Immunosuppression associated with erythropoiesis in genetic low responder mice. 1980

E Conway de Macario, and A J Macario

Priming-memory generation in response to Escherichia coli beta-D-galactosidase occurs without antibody formation in irradiated spleen-cell-transferred C57BL/6J mice, which are genetic low responders to the enzyme. Erythropoiesis abolishes priming-memory generation, so that recipients immunized a few days after cell transfer and erythropoiesis induction do not mount a secondary antibody response. Priming-memory generation in cell recipients immunized 3 days after erythropoiesis induction was less frequent than in controls, whereas no significant differences were found when antigen was given before erythropoiesis induction or 5 days after it. The mean titre of the mice escapint suppression was similar to that of the control mice, which became primed and mounted memory. The titre distribution in both responder groups were also similar, although no high-titered responders were found in the erythropoietic mice. Thus while erythropoiesis induction affects the frequency of priming-memory generation, it does not affect to the same extent the amount of memory generated in those mice escaping suppression. The same distinction was observed when spleen cells from erythropoietic mice, containing 30 to 40% erythroblasts, were transferred into normal mice. However, induction of erythropoiesis in non-irradiated non-cell=transferred mice did not cause suppression.

UI MeSH Term Description Entries
D007108 Immune Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. Immunosuppression (Physiology),Immunosuppressions (Physiology),Tolerance, Immune
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D004920 Erythropoiesis The production of red blood cells (ERYTHROCYTES). In humans, erythrocytes are produced by the YOLK SAC in the first trimester; by the liver in the second trimester; by the BONE MARROW in the third trimester and after birth. In normal individuals, the erythrocyte count in the peripheral blood remains relatively constant implying a balance between the rate of erythrocyte production and rate of destruction. Erythropoieses
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D001616 beta-Galactosidase A group of enzymes that catalyzes the hydrolysis of terminal, non-reducing beta-D-galactose residues in beta-galactosides. Deficiency of beta-Galactosidase A1 may cause GANGLIOSIDOSIS, GM1. Lactases,Dairyaid,Lactaid,Lactogest,Lactrase,beta-D-Galactosidase,beta-Galactosidase A1,beta-Galactosidase A2,beta-Galactosidase A3,beta-Galactosidases,lac Z Protein,Protein, lac Z,beta D Galactosidase,beta Galactosidase,beta Galactosidase A1,beta Galactosidase A2,beta Galactosidase A3,beta Galactosidases
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

E Conway de Macario, and A J Macario
November 1974, The Journal of experimental medicine,
E Conway de Macario, and A J Macario
March 1973, Transplantation proceedings,
E Conway de Macario, and A J Macario
November 1982, Clinical and experimental immunology,
E Conway de Macario, and A J Macario
January 2000, Research communications in molecular pathology and pharmacology,
E Conway de Macario, and A J Macario
January 1983, Immunology letters,
E Conway de Macario, and A J Macario
March 2013, The Journal of experimental biology,
E Conway de Macario, and A J Macario
May 1978, Proceedings of the National Academy of Sciences of the United States of America,
E Conway de Macario, and A J Macario
January 1990, International archives of allergy and applied immunology,
Copied contents to your clipboard!